-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In a study published in the top journal BMJ, researchers aimed to assess the impact of plasma exchange on important outcomes in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis
(AAV) .
We conducted a systematic review and meta-analysis of randomized controlled trials that investigated the effect of plasma exchange in patients with AAV or pauciimmune
.
Researchers searched Medline, Embase and CENTRAL through July 2020
immunity
Meta-analyses used random-effects models to calculate hazard ratios and 95% confidence intervals
.
The quality of evidence was summarized according to the GRADE methodology
infection quality of life
The researchers included nine trials with 1060 participants who met eligibility criteria
.
Plasma exchange had no significant effect on all-cause mortality (relative risk 0.
CONCLUSIONS: For the treatment of AAV, plasma exchange had no significant effect on mortality, reducing the risk of ESKD at 12 months, but increasing the risk of serious infection
.
.
Original source:
Original source:Michael Walsh, et al.
The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis Leave a comment here